Plasma N-terminal—pro Brain Natriuretic Peptide (NT-proBNP) was moderately elevated with a median of 591 (IQR 304–1048) pg/mL, 24 patients (13%) had type 2 diabetes with eight patients (4%) in treatment with metformin. The gene discussed is NPPB; the disease is type 2 diabetes mellitus.